PF-Atlas › Clinical Trials › NCT04297371

Early Detection of Cardiac Impairment and Prediction of RV Hypertrophy in Patients With CTD

CMR examination · Not specified

Registry ID
NCT04297371
Phase
Not specified
Status
Completed
Drug / intervention
CMR examination
Sponsor
RenJi Hospital
Start
2014-07
Enrollment
136
Locations
1

About this trial

There have been reports suggesting that progressive RV failure and death in connective tissue disease (CTD) are related to right ventricular hypertrophy (RVH) and dilation, irrespective of pulmonary arterial hypertension (PAH). The investigators aim to identify cardiac markers that occur before RVH and to investigate predictors of RVH.

View NCT04297371 on ClinicalTrials.gov →

Explore related

All CMR examination trialsAll IPF trials
Medical disclaimer. This page summarizes public trial data for NCT04297371 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.